Furthermore, magnetic resonance imaging (MRI) scans revealed a slower decrease in brain volume in individuals with mild to moderate AD who were treated with GLP‐1 receptor agonist, but the exact implications of these effects require further research.47 The gene discussed is GLP1R; the disease is Alzheimer disease.